Malaysia Nuclear Medicines Market generated $33.68 million in 2020, and is expected to reach $70.24 million by 2028, growing at a CAGR of 9.9% from 2020-2028.
PORTLAND, OREGON, UNITED STATES, January 27, 2022 /
EINPresswire.com/ -- The diagnostic application segment dominated the market in 2020, contributing to more than 90% of the total revenue. However, the therapy treatment segment is projected to register the highest CAGR of 17.0% during the forecast period.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
The Malaysia nuclear medicines market report includes an in-depth analysis of the prime market players such as Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Cardinal Health, Inc., Ion Beam Applications (Ion Beam Applications, SA), GE Healthcare, MERCK KGAA (Sigma Aldrich), Lantheus Holdings, Inc. (Lantheus Medical Imaging, Inc.), Otsuka Holding Co., Ltd. (ABX advanced biochemical compounds GmbH), Novartis AG (Advanced Accelerator Applications S.A.), Siemens Healthcare GmbH, and Taiyo Nippon Sanso Corporation (Mitsubishi Chemical Holdings Corp).
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ
https://www.alliedmarketresearch.com/request-sample/11880
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
โข The pandemic led to decrease in the number of diagnostic and therapeutic procedures with nuclear medicines, as Covid-19 is a communicable disease.
โข Several countries imposed country-wide lockdown to curb the spread of infection. During the lockdown, the number of patient visits to hospitals and clinics dropped significantly.
โข On the other hand, radiopharmaceuticals could help in the detection of the coronavirus. Moreover, it can provide evidence and clarify contradictory concepts in use of non-steroidal and anti-inflammatory drugs for Covid-19.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ
https://www.alliedmarketresearch.com/purchase-enquiry/11880
Rise in incidence of targeted population in Malaysia, surge in adoption of SPECT and PET scans, and increase in geriatric population in Malaysia drive the growth of the Malaysia nuclear medicines market. However, short half-life of radiopharmaceuticals coupled with supply volatility, logistical challenges, and stringent regulatory policies in Malaysia hinders the market. On the contrary, use of radiopharmaceuticals in neurological applications is expected to open lucrative opportunities for the market players in the future.
On the basis of modality, the brachy therapy segment is estimated to manifest the highest CAGR of 18.5% from 2020 to 2028. However, the SPECT segment held the lionโs share in 2020, accounting for around three-fifths of the market.
Based on end users, the research institutes segment is anticipated to manifest the highest CAGR of 13.0% during the forecast period. However, the hospitals and diagnostic centers segment held the largest share in 2020, contributing to around 90% of the Malaysia nuclear medicines market.
๐๐ฒ๐ ๐๐ฒ๐๐ฎ๐ถ๐น๐ฒ๐ฑ ๐๐๐ฉ๐จ๐ซ๐ญ
https://www.alliedmarketresearch.com/malaysia-nuclear-medicines-market-A11515
๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Cardiovascular Diagnostic Testing Market
Meningitis imaging Market
๐๐๐๐๐๐- ๐ ๐๐ฎ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐๐ข๐๐ซ๐๐ซ๐ฒ (๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐จ๐ง-๐๐๐ฆ๐๐ง๐, ๐ฌ๐ฎ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐ฉ๐ซ๐ข๐๐ข๐ง๐ ๐ฆ๐จ๐๐๐ฅ) ๐๐๐๐๐ซ๐๐ ๐๐ฒ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
๐๐๐ญ ๐๐ง ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐ญ๐ก๐ ๐ฅ๐ข๐๐ซ๐๐ซ๐ฒ ๐จ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ญ ๐๐ง๐ฒ ๐ญ๐ข๐ฆ๐ ๐๐ซ๐จ๐ฆ ๐๐ง๐ฒ ๐๐๐ฏ๐ข๐๐ ๐๐ง๐ ๐๐ง๐ฒ๐ฐ๐ก๐๐ซ๐. ๐
๐จ๐ซ ๐ฆ๐จ๐ซ๐ ๐๐๐ญ๐๐ข๐ฅ๐ฌ, ๐๐จ๐ฅ๐ฅ๐จ๐ฐ ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค:
https://www.alliedmarketresearch.com/library-access
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn